Events

Join Bloomberg Law for a complimentary webinar that will take place shortly after the Supreme Court issues its opinion in Association for Molecular Pathology v. Myriad Genetics Inc., to assess the case’s implications. The outcome of the case turns on a fundamental question: Are human genes patentable? But the patent community has a broader concern—the high court’s recent statements that seem to question patent eligibility on a number of other fronts. Will the justices limit their review or deal a significant blow to a broad swath of patents? A panel of legal experts will review the legal arguments and gauge the potential impact on biotechnology and other markets.

SPEAKER(S): Maureen Dry-Wasson, Allegis Group, Inc.; Khalif Ford, Northrop Grumman Corporation; J. Mark Poerio, Paul Hastings LLP; Patricia Spraguer, Express-Scripts

The monitoring and selection of investments and fees for Employee Retirement Income Security Act (ERISA) plans gets more complicated all the time, and 2013 has begun with a significant increase both in litigation and notable court decisions. The faculty members for this program will describe the key cases, lessons to learn, and plan changes to consider.
Register now at bloombergbna.com

SPEAKER(S): William S. Freeman and Greg Chin, Jones Day

When it comes to communicating effectively with their target audiences, public companies today are faced with competing imperatives to optimize their use of social media while observing U.S. Securities and Exchange Commission (SEC) restrictions on “selective disclosure” of material information. Companies that navigate these waters successfully will reap the advantages of powerful communications strategies without risking enforcement action. General counsel and outside attorneys alike will be faced with a continual stream of issues as communications technologies continue to advance.
Register now at bloombergbna.com

SPEAKER(S): Richard J. Grossman and Eileen T. Nugent, Skadden, Arps, Slate, Meagher and Flom LLP; Scott S. Winter, Innisfree M&A Incorporated; Matthew Sherman, Joele Frank Wilkinson Brimmer Katcher

Shareholder activism has increased significantly in the recent past. It has become an effective, even mainstream, way to influence corporate policy. The goals of activist investors have become more nuanced, often seeking incremental change and long-term involvement with target companies rather than just short-term gains.
Register now at bloombergbna.com

SPEAKER(S): George M. Kraw, Kraw Law Group

The Affordable Care Act has major gaps that a gridlocked Congress is unlikely to fill anytime soon. One of the biggest oversights is not defining the role of multiemployer plans in health reform. These plans provide health care coverage to over 20 million Americans, but the ACA left unclear whether the plans would be able to buy the same subsidized health care that will be available to many workers and businesses that are not in multiemployer plans. It also does not address how multiemployer plans can participate in the new health care exchanges (now called marketplaces).
Register now at bloombergbna.com